NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Kardium

Kardium

Private
BurnabyHealthcare & Life Scienceshttps://kardium.com/

Last Round

VC Round

Jul 2, 2025

Total Funding Raised

$264.05M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Kardium is a medical technology company that develops advanced devices for the diagnosis and treatment of atrial fibrillation, offering detailed electrophysiological mapping and pulsed field energy solutions for cardiac tissue ablation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

pulsed field ablationPFAatrial fibrillationAFibcardiac ablationelectrophysiologypulmonary vein isolationPVImedical devicecardiac mappingcatheter ablationelectrophysiology labEP labcardiac surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kardium Comps

Public and private peers based on sector, stage, and business model.

Kardium comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kardium Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 2, 2025
Series DJun 11, 2024
DebtJan 9, 2024
GrantMay 31, 2022
Series DJan 25, 2021
Series A
Feb 7, 2019

Key People

Founding team and executive leadership

Kevin Chaplin

CEO

Executive Team

Koert VandenEnden

Chief Financial Officer

Executive Team

Kardium Investors

Notable investors and investment history

Kardium investors
InvestorRounds
MMCAP VenturesVC Round
Janus Henderson GroupVC Round
EckuityVC Round
Durable Capital Partners LPVC Round, Series D
Eventide FundsVC Round
Fidelity Management & Research CompanySeries D
T. Rowe PriceVC Round, Series D, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Globe Pulsed Field System receives FDA approval and begins commercial launch.

  • Oct 10, 2025

    Leased 225,000 sq ft across ten buildings.

Kardium Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kardium Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kardium's valuation, stock price, and market status.

Firmographic Details

HeadquartersBurnaby
Employee Range636
Year Founded2007
Last FundingJul 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.